2026-05-26
Lucis raises $20M Series A led by Singular
Paris-based Lucis raised $20M in a Series A led by Singular.
Round at a Glance
| Company | Lucis |
| HQ | Paris, France |
| Amount | $20M |
| Round | Series A |
| Date | May 26, 2026 |
| Valuation | Not disclosed |
| Total Disclosed Funding | $28M across multiple rounds |
Company Snapshot
Lucis is a France-based preventive healthcare company. According to the company's public materials, the product helps consumers monitoring their health biomarkers with analysing more than 110 blood biomarkers across metabolic health, hormones, cardiovascular risk, inflammation, and nutrient levels.
Investors in This Round
| Investor | Investor HQ Country | Notes |
|---|---|---|
| Singular | France | Lead |
| General Catalyst | United States | Returning investor |
| Y Combinator | United States | Returning investor |
Known Cap Table
| Investor | Round(s) | Investor HQ Country |
|---|---|---|
| Singular | Series A | France |
| General Catalyst | Series A | United States |
| Y Combinator | Series A | United States |
Total disclosed funding: $20M across 1 round.